Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton.
Song OR, Queval CJ, Iantomasi R, Delorme V, Marion S, Veyron-Churlet R, Werkmeister E, Popoff M, Ricard I, Jouny S, Deboosere N, Lafont F, Baulard A, Yeramian E, Marsollier L, Hoffmann E, Brodin P. Song OR, et al. Among authors: hoffmann e. EMBO Rep. 2018 Jan;19(1):29-42. doi: 10.15252/embr.201744371. Epub 2017 Nov 15. EMBO Rep. 2018. PMID: 29141986 Free PMC article.
Host-pathogen systems for early drug discovery against tuberculosis.
Trofimov V, Costa-Gouveia J, Hoffmann E, Brodin P. Trofimov V, et al. Among authors: hoffmann e. Curr Opin Microbiol. 2017 Oct;39:143-151. doi: 10.1016/j.mib.2017.11.017. Epub 2017 Nov 24. Curr Opin Microbiol. 2017. PMID: 29179041 Review.
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
Mori G, Orena BS, Franch C, Mitchenall LA, Godbole AA, Rodrigues L, Aguilar-Pérez C, Zemanová J, Huszár S, Forbak M, Lane TR, Sabbah M, Deboosere N, Frita R, Vandeputte A, Hoffmann E, Russo R, Connell N, Veilleux C, Jha RK, Kumar P, Freundlich JS, Brodin P, Aínsa JA, Nagaraja V, Maxwell A, Mikušová K, Pasca MR, Ekins S. Mori G, et al. Among authors: hoffmann e. Tuberculosis (Edinb). 2018 Sep;112:98-109. doi: 10.1016/j.tube.2018.08.004. Epub 2018 Aug 11. Tuberculosis (Edinb). 2018. PMID: 30205975
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis.
Machelart A, Salzano G, Li X, Demars A, Debrie AS, Menendez-Miranda M, Pancani E, Jouny S, Hoffmann E, Deboosere N, Belhaouane I, Rouanet C, Simar S, Talahari S, Giannini V, Villemagne B, Flipo M, Brosch R, Nesslany F, Deprez B, Muraille E, Locht C, Baulard AR, Willand N, Majlessi L, Gref R, Brodin P. Machelart A, et al. Among authors: hoffmann e. ACS Nano. 2019 Apr 23;13(4):3992-4007. doi: 10.1021/acsnano.8b07902. Epub 2019 Mar 8. ACS Nano. 2019. PMID: 30822386 Free PMC article.
T(oo)bAd.
Brodin P, Hoffmann E. Brodin P, et al. Among authors: hoffmann e. Nat Chem Biol. 2019 Sep;15(9):849-850. doi: 10.1038/s41589-019-0347-x. Nat Chem Biol. 2019. PMID: 31427816 No abstract available.
Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies.
Belhaouane I, Hoffmann E, Chamaillard M, Brodin P, Machelart A. Belhaouane I, et al. Among authors: hoffmann e. Front Immunol. 2020 Sep 25;11:569127. doi: 10.3389/fimmu.2020.569127. eCollection 2020. Front Immunol. 2020. PMID: 33072109 Free PMC article. Review.
[No title available]
[No authors listed] [No authors listed] PMID: 33451790
1,464 results